Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

Similar documents
Current status on other health effects:

Epidemiologic Measure of Association

Why Do We Treat Obesity? Epidemiology

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

Prevalence of cerebrovascular accidents (CVA) in obese hypertensives among inpatients of Govt.General Hospital, Guntur

Joint Impact of Smoking and Hypertension on Cardiovascular Disease and All-Cause Mortality in Japan: NIPPON DATA80, a 19-Year Follow-Up

Supplementary Online Content

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal Circumference

Supplement materials:

Depok-Indonesia STEPS Survey 2003

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study

Magnetic resonance imaging, image analysis:visual scoring of white matter

Epidemiology of Obesity in Japan

UW MIRT 2005 ABSTRACTS

Effect of Medicine Adherence on the Occurrence of Cerebrovascular Disorders in Diabetes Mellitus Patients

5. Cardiovascular Disease & Stroke

Vomiting Should Be a Prompt Predictor of Stroke Outcome

Usefulness of a large automated health records database in pharmacoepidemiology

A n aly tical m e t h o d s

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study

Heart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved.

Hypertension is a major risk factor for stroke in developed

T. Suithichaiyakul Cardiomed Chula

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

Smoking and atherosclerotic cardiovascular disease in women with lower levels of serum cholesterol

Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies

Diet-Related Factors, Educational Levels and Blood Pressure in a Chinese Population Sample: Findings from the Japan-China Cooperative Research Project

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

Guidelines on cardiovascular risk assessment and management

Clinical Studies 129

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI.

CONTRIBUTING FACTORS FOR STROKE:

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

Hypertension Guidelines 2017

What is hypertension?

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Study on occurrence of metabolic syndrome among patients with stroke: a descriptive study

The Latest Generation of Clinical

Predicting failure to follow-up screened high blood pressure in Japan: a cohort study

Physical Activity, Sedentary Behaviors and the Incidence of Type 2 Diabetes Mellitus: The Multi-

Blood Pressure Management in Acute Ischemic Stroke

The Impact of Smoking on Acute Ischemic Stroke

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Cardiovascular Risk Assessment and Management Making a Difference

Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

Identification of subjects at high risk for cardiovascular disease

Pathology of Hypertension

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Gender Differences in Physical Inactivity and Cardiac Events in Men and Women with Type 2 Diabetes

doi: /j.atherosclerosis

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Division of Neurosurgery, Institute of Brain Diseases, Tohoku University School of Medicine, Sendai 982

Objectives. Describe results and implications of recent landmark hypertension trials

Original Research Article

KEEP Summary Figures S32. Am J Kidney Dis. 2011;57(3)(suppl 2):S32-S56

Non communicable Diseases

Blood Pressure Treatment Goals

Causes of Poor BP control Rates

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

KEEP Summary Figures S40. Am J Kidney Dis. 2012;59(3)(suppl 2):S40-S64

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Supplementary Online Content

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2015 August 01.

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Prevalence of Cardiac Risk Factors among People Attending an Exhibition

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication

Population Attributable Fraction of Mortality Associated with Tobacco Smoking in Japan: A Pooled Analysis of Three Large-scale Cohort Studies

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

Keizo TAKEMI. Member, House of Councilors

Sex Differences in Stroke Risk and Quality of Life after Stroke

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Stroke is the third leading cause of death in the

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China

Appendix: Supplementary tables [posted as supplied by author]

EuroPrevent 2010 Fatal versus total events in risk assessment models

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Treating Hypertension in 2018: What Makes the Most Sense Today?

Seasonal variation in blood pressure and its relationship with outdoor air temperature in 10 diverse regions of China: the China Kadoorie Biobank

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension

2/7/

YOUNG ADULT MEN AND MIDDLEaged

Fasting insulin and risk of cerebral infarction in a Japanese general population: The Jichi Medical School Cohort Study

Predicting and changing the future for people with CKD

Transcription:

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Manabu Izumi, Kazuo Suzuki, Tetsuya Sakamoto and Masato Hayashi Jichi Medical University Research Institute for Brain and Blood vessels-akita

Background Stroke is one of the leading causes of death and disability in Akita, Japan, same as all over the world. Stroke prevention is considered one of the best strategies for improving public health. Hypertension, diabetes mellitus, hyperlipidemia, obesity, smoking, and drinking are well known as risk factors for stroke all over the world. While, differences of the distribution of risk factors exist in stroke subtypes, countries, and races. To prevent stroke in target populations, it is important to identify specific risk factors by stroke subtype, location, and race.

Purpose We performed a retrospective cohort study to assess risk factors for stroke depending on the subtypes in Akita, northern territory of Japan. Japanese World Map

Where is Akita? And what is characteristics of Akita? Weather ; (Summer is like Rome and winter is like Stockholm) Almost one race Japanese and health-insurance system that covers all of its citizens Stroke subtype; (Cerebral infarction; CI, Cerebral hemorrhage; CI and Subarachnoid hemorrhage; SAH) The rose line means latitude of 40 degrees north.

Characteristics of Akita Prefecture The climate in Akita is characteristically marked by long winters and short summers. we have a heavy fall of snow in winter. Akita Prefecture shares the same latitude with Beijing, Madrid and New York. Area Population Mortality of stroke 11,434 km2 5th in Japan 1,142,799 people 5th in Japan 1613 /million 1st in Japan Research Institute for Brain and Vessels-Akita, Specialist Hospital for Stroke

Methods: Mass health screening data was collected from the Akita Prefectural Federation of Agricultural Cooperative for Health and Welfare from 1991 to 1998. Cerebrovascular events were determined from the Akita stroke registry from 1991 to 2001. Then, clinical risk factors for stroke, such as hypertension, hyperlipidemia and diabetes mellitus, were assessed in the different subtypes of stroke. Disease classifications were made using the international Classification of ICD9 and classifications were follows: cerebral infarction (CI), cerebral hemorrhage (CH), and subarachnoid hemorrhage (SAH). The Akita stoke registry consisted of the basis of informed consent from all patients with stroke event who were admitted to a hospital and included all stroke events and stroke related deaths that required immediate hospitalization in all emergency medical facilities of Akita Prefecture.

Methods: A first-ever stroke occurring less than 3 years after the screening examination (i.e., from 1991 to 2001) was defined as a stroke event. As stroke risk factors, age, sex, history of DM, blood pressure (BP), serum total cholesterol (TC), body mass index (BMI), smoking, and drinking were assessed. Significant risk factors were detected by multivariable logistic regression analysis. Reductions in risk and 95% CI were estimated with use of the Cox proportional-hazards model. We also assessed interactions with a p value of <0.001 (two-sided test) being considered statistically significant.

Result: Table 1 Number of subject and stroke event by age and sex. Men Age(y.o.) Non stroke CH CI SAH Total 30-49 33435 27 27 23 33512 50-59 19460 56 82 25 19623 60-69 15482 72 178 33 15765 70-79 6156 47 145 8 6356 80-1026 15 33 0 1074 total 75559 217 465 89 76330 Women Age(y.o.) Non stroke CH CI SAH Total 30-49 30471 3 14 21 30509 50-59 20183 33 33 19 20268 60-69 20198 65 83 60 20406 70-79 8100 39 114 29 8282 80-1058 4 30 5 1097 Total 80010 144 274 134 80562

Result: Table 2 Age-specific stroke incidence /100,000 by sex Men Age(y.o.) CH CI SAH ALL 30-39 6.2 3.1 15.6 24.9 40-49 36.6 38 26.3 100.9 50-59 95.1 139.3 42.5 276.9 60-69 152.2 376.4 69.8 598.4 70-79 246.5 760.4 42 1048.9 80-465.5 1024.2-1489.8 Women Age CH CI SAH ALL 30-39 - 10.1 23.5 33.5 40-49 4.9 17.8 22.7 45.4 50-59 54.3 54.3 31.2 139.8 60-69 106.2 135.6 98 339.8 70-79 157 458.8 116.7 732.5 80-121.5 911.6 151.9 1185.1

Result: Table 3 Risk factors comparison by stroke event and sex Men Women Factors Non-stroke Stroke Non-stroke Stroke Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Age (years old) 53.1 (53.0, 53.2) 64.5 (63.7, 65.2) 54.8 (54.7, 54.9) 66.7 (65.8, 67.5) SBP (mmhg) 130.8 (130.6, 130.9) 144.7 (143.2, 146.1) 127.6 (127.4, 127.7) 145.5 (143.8, 147.1) DBP (mmhg) 80 ( 79.9, 80.1) 85.6 ( 84.7, 86.5) 76.1 ( 76.0, 76.2) 83.3 ( 82.4, 84.3) BMI 23.5 ( 23.4, 23.6) 23.3 ( 23.1, 23.5) 23.5 ( 23.4, 23.6) 24.1 ( 23.8, 24.4) TC (mg/dl) 197.4 (197.1, 197.6) 191 (188.5, 193.5) 205.3 (205.0, 205.5) 210.7 (207.6, 213.8) Drinking (number) No 63509 610 p<0.001 79430 545 p=0.129 Yes 12053 161 580 7 Smoking (number) No 60785 546 p<0.001 78518 543 p=0.761 1-10/day 2680 64 1002 5 11-20/day 8523 129 441 4 >=21 3571 32 49 0 DM (number) No 73833 737 p<0.001 78368 524 p<0.001 Yes 1726 34 1642 26 TC; Total Cholesterol, BMI; Body mass index, DM; Diabetes mullitus, SBP; Systolic BP and DBP; Diastolic BP

Relative risk of the risk factors of stroke subtypes by multi logistic regression analysis Factors Intracranial Brain Subarachnoid Total hemorrhage(95%ci) infarction(95%ci) hemorrhage(95%ci) Stroke(95%CI) Sex Male 1 1 1 1 Female 0.7( 0.6, 0.9) 0.6( 0.5, 0.7) 1.8( 1.3, 2.5) 0.7 (0.6, 0.8) Age 30-49yo 1 1 1 1 50-59 3.5( 2.3, 5.4) 4.0( 2.8, 5.8) 1.3( 0.8, 1.9) 2.9 (2.3, 3.6) 60-69 5.1( 3.4, 7.7) 9.4( 6.7,13.2) 2.4( 1.7, 3.5) 5.6 (4.6, 6.9) 70-79 7.1( 4.6,10.9) 22.5(16.0,31.6) 2.1( 1.3, 3.3) 10.1 (8.1,12.5) 80-89 9.4( 5.2,17.0) 36.4(24.3,54.7) 1.7( 0.7, 4.3) 14.7(11.0,19.6) Classification of BP Optimal 1 1 1 1 Normal 1.7( 0.9, 3.4) 1.4( 1.0, 1.9) 2.8( 1.5, 5.4) 1.6 (1.2, 2.1) Normal high 3.7( 2.0, 6.7) 1.8( 1.3, 2.4) 2.8( 1.5, 5.4) 2.2 (1.7, 2.9) Mild HT 6.6( 3.7,11.7) 2.2( 1.6, 2.9) 6.4( 3.5,11.5) 3.3 (2.6, 4.2) Medium HT 13.1( 7.2,23.7) 2.6( 1.9, 3.6) 10.0( 5.3,18.7) 4.9 (3.8, 6.3) Severe HT 24.9(13.2,46.9) 5.0( 3.4, 7.3) 16.1( 7.7,33.5) 9.1 (6.8,12.2)

Relative risk of the risk factors of stroke subtypes by multi logistic regression analysis Factors Intracranial Brain Subarachnoid Total hemorrhage(95%ci) infarction(95%ci) hemorrhage(95%ci) Stroke(95%CI) Body mass index less than 18.5 1.3( 0.8, 2.1) 0.6( 0.4, 0.9) 1.5( 0.9, 2.6) 0.9 (0.7, 1.2) 18.5-25 1 1 1 1 25-30 1.0( 0.8, 1.3) 1.2( 1.0, 1.4) 0.7( 0.5, 1.0) 1.0 (0.9, 1.2) more than 30 1.8( 1.2, 2.9) 1.1( 0.7, 1.7) 1.2( 0.6, 2.2) 1.3 (1.0, 1.8) Total cholesterol <160mg/dl 1 1 1 1 160-199 0.6( 0.5, 0.9) 0.9( 0.7, 1.1) 0.4( 0.3, 0.6) 0.7 (0.6, 0.8) 200-239 0.6( 0.4, 0.8) 0.9( 0.7, 1.2) 0.5( 0.4, 0.8) 0.7 (0.6, 0.9) 240-279 0.6( 0.4, 0.9) 0.9( 0.7, 1.2) 0.4( 0.2, 0.7) 0.9 (0.6, 1.4) >=280mg/dl 0.6( 0.3, 1.3) 1.7( 1.1, 2.6) 0.2( 0.0, 0.8) 0.9 (0.8, 1.1) Drinking No 1 1 1 1 Yes 1.2( 0.9, 1.7) 0.8( 0.7, 1.1) 1.0( 0.6, 1.7) 1.0 (0.8, 1.1) Smoking No 1 1 1 1 <10/day 0.9( 0.5, 1.6) 1.7( 1.3, 2.3) 1.5( 0.7, 3.1) 1.5 (1.1, 1.9) 11-20/day 1.0( 0.6, 1.5) 1.9( 1.5, 2.5) 1.3( 0.7, 2.3) 1.5 (1.3, 1.9) >=21 1.2( 0.6, 2.5) 1.5( 0.9, 2.5) 2.4( 1.1, 5.3) 1.5 (1.1, 2.2) Diabetes mellitus No 1 1 1 1 Yes 0.9( 0.5, 1.5) 1.6( 1.2, 2.1) 0.4( 0.1, 1.2) 1.2 (0.9, 1.6)

Relative risk Relative risk of the combinations with blood pressure and cholesterol against the lowest in hemorrhagic stroke 15 10 5 0 3.7 7.8 14.8 10.5 3.8 4.5 1.6 1.9 1.5 1.0 0.5 0.9 1.0 <160-200 -240 >240 Total cholesterol mg/dl 7.4 8.0 3.3 normal preht HT-1 HT-2 JNC7 classification of blood pressure

Discussion: Hypertension is the strongest risk factor for stroke, especially for hemorrhagic stroke. Our results support the idea that stroke incidence will be increased along with higher BP level. Interestingly, however, this phenomenon is observed not only among hypertensive categories but also within normal BP levels. Our register showed that 40% of all stroke events occurred in either mildly hypertensive cases who were not receiving any pharmacologic therapy or normal BP cases. Even though high BP is associated with high stroke risk, mildly high BP is still a risk factor for stroke. Therefore, we should put the eyes on the hidden or untreated normal high BP person for reducing stroke incident.

Discussion: Our data also suggest that TC <160 mg/dl is a risk factor for hemorrhagic stroke, whereas levels >280 mg/dl are a risk factor for CI. The reasons for this phenomenon seem to be related to the high incidence of CH and low incidence of CI in our study compared with Western countries. The interaction of BP and TC is an important factor for CH among Japanese subjects. Our study showed that the highest BP combined with the lowest TC level was the strongest risk factor for CH. Low TC contributed to the risk of CH across all BP levels. We could reveal the synergic effect on hemorrhagic stroke between low TC and hypertension.

Conclusion: Japanese subjects in this study showed a high proportion of hemorrhagic stroke. The relative risk of all stroke subtypes are increasing with higher blood pressure. Moreover, high blood pressure and low TC (<160 mg/dl) were the strongest risk factor for hemorrhagic stroke. Future studies are needed to determine if typical Japanese food consumption causes high blood pressure and low TC and is associated with the incidence of stroke.